Literature DB >> 16611664

Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia.

James P Burke1, Thomas Rhodes, Debra J Jacobson, Michaela E McGree, Rosebud O Roberts, Cynthia J Girman, Michael M Lieber, Steven J Jacobsen.   

Abstract

The authors investigated the association of anthropometric measures with the presence and progression of components of benign prostatic hyperplasia (BPH) and a clinical outcome of BPH in a cohort of healthy, Caucasian men aged 40-79 years that was randomly selected from the Olmsted County, Minnesota, population beginning in 1990. Exclusionary criteria included prostate or bladder surgery, urethral surgery or stricture, or medical or other neurologic conditions that could affect normal urinary function. Height, weight, and waist and hip circumferences were measured. Components of BPH, including American Urological Association Symptom Index scores, peak urinary flow rate, and prostate volume, were assessed on a randomly selected subsample. Acute urinary retention was assessed through review of community medical records. There were few significant associations of anthropometric measures with the presence or progression of components of BPH or clinical outcome of BPH, and there were no instances where the point estimates for the BPH components suggested a dose-response effect. The authors conclude that anthropometric measures are not significantly associated with the presence or progression of BPH as measured by American Urological Association Symptom Index scores, peak urinary flow rate, prostate volume, or acute urinary retention. These data provide no evidence of a consistent significant relation between anthropometric measures and BPH.

Entities:  

Mesh:

Year:  2006        PMID: 16611664     DOI: 10.1093/aje/kwj151

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

Review 1.  Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.

Authors:  Linda Vignozzi; Mauro Gacci; Mario Maggi
Journal:  Nat Rev Urol       Date:  2016-01-12       Impact factor: 14.432

2.  Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study.

Authors:  J Kellogg Parsons; Karen Messer; Martha White; Elizabeth Barrett-Connor; Douglas C Bauer; Lynn M Marshall
Journal:  Eur Urol       Date:  2011-07-23       Impact factor: 20.096

3.  A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms.

Authors:  Alison M Mondul; Edward Giovannucci; Elizabeth A Platz
Journal:  J Urol       Date:  2013-09-25       Impact factor: 7.450

4.  Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms.

Authors:  Jennifer L St Sauver; Steven J Jacobsen; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; Ajay Nehra; Veronique L Roger; Michael M Lieber
Journal:  BJU Int       Date:  2010-08-26       Impact factor: 5.588

5.  Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times.

Authors:  Michael M Lieber; Thomas Rhodes; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; Steven J Jacobsen; Jennifer L St Sauver
Journal:  BJU Int       Date:  2009-07-07       Impact factor: 5.588

6.  Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

Authors:  Jay H Fowke; Saundra Motley; Qi Dai; Raoul Concepcion; Daniel A Barocas
Journal:  Cancer Lett       Date:  2012-10-16       Impact factor: 8.679

7.  Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey.

Authors:  Varant Kupelian; Kevin T McVary; Steven A Kaplan; Susan A Hall; Carol L Link; Lalitha Padmanabhan Aiyer; Patrick Mollon; Nihad Tamimi; Raymond C Rosen; John B McKinlay
Journal:  J Urol       Date:  2009-06-18       Impact factor: 7.450

8.  PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation.

Authors:  D W Strand; M Jiang; T A Murphy; Y Yi; K C Konvinse; O E Franco; Y Wang; J D Young; S W Hayward
Journal:  Cell Death Dis       Date:  2012-08-09       Impact factor: 8.469

9.  Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age.

Authors:  Sung Jin Yim; Young Sam Cho; Kwan Joong Joo
Journal:  Korean J Urol       Date:  2011-06-17

10.  Does Metabolic Syndrome or its Components Correlate With Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients?

Authors:  Onur Telli; Arif Demirbas; Mucahit Kabar; Mehmet Ali Karagoz; Hasmet Sarici; Berkan Resorlu
Journal:  Nephrourol Mon       Date:  2015-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.